OOIR: Observatory of International Research

Papers

(The TQCC of Rheumatic Disease Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Copyright	104
Osteoarthritis Treatment Guidelines from Six Professional Societies	82
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	52
The Current Status of Exercise Applications as Medicine in Myositis Diseases on Behalf of MIHRA ICERS and MIHRA Clinical Trial Sites Network	37
Contents	34
Pediatric Rheumatology Comes of Age: Part II	33
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	26
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	21
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	21
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	21
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	21
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	20
Copyright	19
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	19
COPA Syndrome from Diagnosis to Treatment	17
The Short and Long of COVID-19	16
Forthcoming Issues	16
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	16
Lessons Learned from the COVID-19 Pandemic in Rheumatology	15
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	15
Taxonomy of Quality of Care Indicators	12
Newer Immunosuppressants for Rheumatologic Disease	12
Imaging Challenges and Developments in Large-vessel Vasculitis	12
Contributors	12
Pulmonary Hypertension Associated with Connective Tissue Disease	11

De novo Connective Tissue Disorders as Immune-related Adverse Events	11
Copyright	11
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	11
Vaccinations in Patients with Rheumatic Disease	11
Contents	11
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	11
Expanding the Treatment Team	10
It Takes Oysters to Generate Pearls	10
Primary Cardiac Involvement in Systemic Sclerosis	10
Copyright	9
Uveitis in Children and Adolescents	9
Cardiac MRI in Rheumatic Disease	8
Daniel J McCarty, MD: A Giant of Rheumatology	8
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	8
Charles L Christian	8
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	8
Preventative Care in Scleroderma	7
Rheumatology Pearls for the Primary Care Physician	7
E Carwile LeRoy, MD	7
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	7
Scleroderma: Best Approaches to Patient Care	7
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	7
Copyright	7
COVID-19 and Rheumatology	7
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases	7
Imaging of Pulmonary Manifestations of Connective Tissue Disease	7
Chronic Nonbacterial Osteomyelitis	7
Imaging of the Major Salivary Glands in Rheumatic Disease	6
A Guide to Contemporary Clinical Practice Guidelines	6
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus	6
Contents	6
Contributors	6
Guideline Development and Implementation in Rheumatic Disease	6
Heart Failure in Rheumatic Disease	6
The Spectrum of Myocardial Disease in Idiopathic Inflammatory Myopathies	6
Contents	6
The Challenges of New Biologic Therapies in Pediatrics	6
Sustainable Health Care and Advocacy for Rheumatologists	6
Beyond Coronary Artery Disease	5
Forthcoming Issues	5
Impacts of Storms, Precipitation, Drought, and Water Quality on Rheumatic Diseases	5
Genetic Defects in Early-Onset Inflammatory Bowel Disease	5
SARS-CoV-2 Infection and COVID-19 in Children	5
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy	5
Contributors	5
The Role of Psychology in Pediatric Rheumatic Diseases	5
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	5
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	5
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus	5

Copyright	5
Cardiovascular Health in Pediatric Rheumatologic Diseases	5
Myositis	5
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	4
Ambient PM2.5 Exposure and the Incidence of Systemic Lupus Erythematosus	4
Expanding IPEX: Inborn Errors of Regulatory T Cells	4
Copyright	4
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	4
Management and Cure of Gouty Arthritis	4
Role of Environment in Pediatric Rheumatic Diseases	4
Imaging in Inflammatory Bowel Disease	4
Health Care Utilization	4
Emerging and Expanding Infections due to Climate Change of Concern to Rheumatologists	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4
Treatment Guidelines in Gout	4
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	4
CARRA	4
Molecular Biomarkers and Clinical Predictors of Psoriatic Arthritis	4
Contents	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
Dual-Energy Computed Tomography Applications in Rheumatology	4
Patient Engagement in Pediatric Rheumatology Research	4